AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Poulsen, TS Silahtaroglu, AN Gisselo, CG Gaarsdal, E Rasmussen, T Tommerup, N Johnsen, HE
Citation: Ts. Poulsen et al., Detection of illegitimate rearrangement within the immunoglobulin locus on14q32.3 in B-cell malignancies using end-sequenced probes, GENE CHROM, 32(3), 2001, pp. 265-274

Authors: Knudsen, LM Nikolaisen, K Gaarsdal, E Johnsen, HE
Citation: Lm. Knudsen et al., Kinetic studies during peripheral blood stem cell collection show CD34+cell recruitment intra-apheresis, J CLIN APH, 16(3), 2001, pp. 114-119

Authors: Johnsen, HE
Citation: He. Johnsen, Clinical practice and future needs in recombinant human granulocyte colony-stimulating factor treatment: a review of randomized trials in clinical haemato-oncology, J INT MED R, 29(2), 2001, pp. 87-99

Authors: Serke, S Johnsen, HE
Citation: S. Serke et He. Johnsen, A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts, BONE MAR TR, 27(5), 2001, pp. 463-470

Authors: Rasmussen, T Johnsen, HE
Citation: T. Rasmussen et He. Johnsen, Controversies surrounding the circulating clonotypic B lymphocytes in multiple myeloma - Response, BLOOD, 97(9), 2001, pp. 2913-2914

Authors: Rasmussen, T Dahl, IMS Jensen, L Johnsen, HE
Citation: T. Rasmussen et al., CD68(+)/CD83(+)/CD1a(-) dendritic cell subsets from patients with multiplemyeloma are not infected with human herpesvirus 8, MED ONCOL, 17(3), 2000, pp. 189-194

Authors: Baech, J Johnsen, HE
Citation: J. Baech et He. Johnsen, Technical aspects and clinical impact of hematopoietic progenitor subset quantification, STEM CELLS, 18(2), 2000, pp. 76-86

Authors: Rasmussen, T Poulsen, TS Honore, L Johnsen, HE
Citation: T. Rasmussen et al., Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay, EXP HEMATOL, 28(9), 2000, pp. 1039-1045

Authors: Rasmussen, T Jensen, L Johnsen, HE
Citation: T. Rasmussen et al., The clonal hierachy in multiple myeloma, ACTA ONCOL, 39(7), 2000, pp. 765-770

Authors: Knudsen, LM Jensen, L Gaarsdal, E Nikolaisen, K Johnsen, HE
Citation: Lm. Knudsen et al., A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF, BONE MAR TR, 26(7), 2000, pp. 717-722

Authors: Schiodt, I Jensen, CH Kjaersgaard, E Gaarsdal, E Nikolajsen, K Johnsen, HE
Citation: I. Schiodt et al., Flow cytometric detection of growth factor receptors in autografts and analysis of growth factor concentrations in autologous stem cell transplantation: possible significance for platelet recovery, BONE MAR TR, 26(5), 2000, pp. 525-531

Authors: Richel, DJ Johnsen, HE Canon, J Guillaume, T Schaafsma, MR Schenkeveld, C Hansen, SW McNiece, I Gringeri, AJ Briddell, R Ewen, C Davies, R Freeman, J Miltenyi, S Symann, M
Citation: Dj. Richel et al., Highly purified CD34(+) cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients, BONE MAR TR, 25(3), 2000, pp. 243-249

Authors: Rasmussen, T Jensen, L Johnsen, HE
Citation: T. Rasmussen et al., Levels of circulating CD19(+) cells in patients with multiple myeloma, BLOOD, 95(12), 2000, pp. 4020-4021

Authors: Knudsen, LM Rasmussen, T Jensen, L Johnsen, HE
Citation: Lm. Knudsen et al., Reduced bone marrow stem cell pool and progenitor mobilisation in multiplemyeloma after melphalan treatment, MED ONCOL, 16(4), 1999, pp. 245-254

Authors: Johnsen, HE Baech, J Nikolajsen, K
Citation: He. Johnsen et al., Validation of the Nordic flow cytometry standard for CD34(+) cell enumeration in blood and autografts: Report from the third workshop, J HEMATOTH, 8(1), 1999, pp. 15-28

Authors: Serke, S Huhn, D Johnsen, HE Herrmann, R
Citation: S. Serke et al., Detrimental effects of prechemotherapy filgrastim, J CL ONCOL, 17(3), 1999, pp. 1088-1089

Authors: Knudsen, LM Jensen, L Jarlbaek, L Hansen, PG Hansen, SW Drivsholm, L Nikolaisen, K Gaarsdal, E Johnsen, HE
Citation: Lm. Knudsen et al., Subsets of CD34(+) hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation, HAEMATOLOG, 84(6), 1999, pp. 517-524

Authors: Johnsen, HE Serke, S
Citation: He. Johnsen et S. Serke, Simplicity or complexity is not the question, EXP HEMATOL, 27(6), 1999, pp. 977-977

Authors: Schiodt, I Knudsen, LM Jensen, L Nikolajsen, E Gaarsdal, E Johnsen, HE
Citation: I. Schiodt et al., Flow cytometry comparison of CD34(+) subsets in bone marrow and peripheralblood after priming with glycosylated or non-glycosylated rhG-CSF - Response, BONE MAR TR, 24(4), 1999, pp. 442-443

Authors: Johnsen, HE Hutchings, M Taaning, E Rasmussen, T Knudsen, LM Hansen, SW Andersen, H Gaarsdal, E Jensen, L Nikolajsen, K Kjaesgard, E Hansen, NE
Citation: He. Johnsen et al., Selective loss of progenitor subsets following clinical CD34(+) cell enrichment by magnetic field, magnetic beads or chromatography separation, BONE MAR TR, 24(12), 1999, pp. 1329-1336

Authors: Rasmussen, T Jensen, L Honore, L Andersen, H Johnsen, HE
Citation: T. Rasmussen et al., Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays, BR J HAEM, 107(4), 1999, pp. 818-824

Authors: Rasmussen, T Kastrup, J Knudsen, LM Johnsen, HE
Citation: T. Rasmussen et al., High numbers of clonal CD19(+) cells in the peripheral blood of a patient with multiple myeloma, BR J HAEM, 105(1), 1999, pp. 265-267

Authors: Johnsen, HE
Citation: He. Johnsen, Does recombinant human granulocyte colony-stimulating factor really prime marrow stem cells in mice and humans?, BLOOD, 93(12), 1999, pp. 4446-4447

Authors: Rasmussen, T Honore, L Johnsen, HE
Citation: T. Rasmussen et al., Identification and characterisation of malignant cells using RT-PCR on single flow-sorted cells, MED ONCOL, 15(2), 1998, pp. 96-102

Authors: Schiodt, I Bergmann, OJ Johnsen, HE Hansen, NE
Citation: I. Schiodt et al., Early infections after autologous transplantation for haematological malignancies, MED ONCOL, 15(2), 1998, pp. 103-108
Risultati: 1-25 |